MedPal AI - Raises £5 million to accelerate new opportunities

Digital heath business MedPal AI has raised c.£5 million via an equity raise of 142,857,133 new shares at a price of 3.5p per share. While this was at a 12.5% discount to the previous day’s closing price of 4p it was at a 40% premium to April’s £3 million raise at 2.5p per share. Encouragingly, the fundraise is said to have been strongly supported by institutional and new investors.

The net proceeds of the raise are going to be spent on two main strategic initiatives, with the remainder being used for working capital to support corporate costs and ongoing growth in NHS dispensing volumes.

For more information about MedPal AI visit the company’s dedicated Optimo Research page HERE

Sign up to receive our full investment research notes on MedPal AI, and other small cap growth companies, as soon as they are published.

Disclosures

MedPal AI is a corporate client of Optimo Research Limited.

Disclaimers

This article, and all articles on the Optimo Research blog, are for information purposes only. Our blog articles do not constitute an investment recommendation or personal advice. Nothing in our blog articles should be construed as an offer or the solicitation of an offer to buy or sell securities by us and, as we have no knowledge of your individual situation and circumstances, you should not make any investment decision without consulting a fully qualified financial adviser. Your capital is at risk by investing in the financial instruments issued by the companies discussed. For full disclosures, disclaimers and risk warnings click here.